sumatriptan iontophoretic – transdermal system (Zecuity)

March 31, 2015 − by Contributor − in Archived − Comments Off on sumatriptan iontophoretic – transdermal system (Zecuity)

sumatriptan iontophoretic – transdermal system (Zecuity)

Pharmacy Author:

Medical and Pharmacy Editor:

GENERIC NAME: sumatriptan iontophoretic transdermal system


DRUG CLASS AND MECHANISM: Zecuity is anti-migraine drug that is delivered
through the skin or transdermally. Zecuity is a serotonin (5HT) 1b/1d receptor
agonist that is used for the acute treatment of
migraine headaches in adults.

Zecuity contains the drug, sumatriptan, which has been previously available
as tablets, injections, and nasal spray. As the exact cause of migraine
headaches remains unclear, the mechanism by which sumatriptan helps to treat
migraine headaches is not well understood. However, it is thought that
sumatriptan helps to alleviate migraine pain by decreasing the dilation of blood
vessels in the brain and inhibiting the release of inflammatory chemicals in the
brain. Zecuity is designed to deliver sumatriptan through the skin with
application of a battery operated device on the upper arm or thigh.

Zecuity was
approved by the FDA in January, 2013.

PRESCRIBED FOR: Zecuity is used for the acute treatment of migraine headaches
with or without aura in adults. Zecuity should not be used to prevent migraine
headaches, and should be reserved for use in patients previously diagnosed with
migraine headaches.

SIDE EFFECTS: The most common side effects of Zecuity include:

  • pain,
  • tingling,
  • itching,
  • warmth,
  • discomfort or change in the skin color at the application site.

Medically Reviewed by a Doctor on 2/9/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Back to Medications Index

Source:sumatriptan iontophoretic – transdermal system (Zecuity)